CANO Stock Recent News

Value-based care is a solution to the challenges that U.S. healthcare is facing. Cano Health, Inc.'s leading position stems from its proprietary platform and relationships with key stakeholders.

The company, which operates senior-oriented primary care centers, is running low on cash.

Concerns about the company's liquidity may be driving some investors away.

Third Point's Daniel Loeb (Trades, Portfolio) disclosed last week he upped his firm's stake in Global Blue Group Holding AG ( GB , Financial) by 15.62% following its quarterly earnings report.

Lowered guidance and big third-quarter losses worried investors.

Cano Health, Inc. arguably has the most asymmetrical risk/reward profile we have encountered in over 20 years of managing hedge fund capital and personal wealth. The company is a leader in one of the hottest M&A markets, with potential buyers far outnumbering a dwindling list of sellers.

The value-based healthcare insurer is seen as a potential buyout candidate.

Investors reacted negatively to the company's Q3 update.

Cano Health, Inc. (NYSE:CANO ) Q3 2022 Earnings Conference Call November 9, 2022 5:00 PM ET Company Participants Marlow Hernandez - Chairman and Chief Executive Officer Brian Koppy - Chief Financial Officer Conference Call Participants Andrew Mok - UBS Adam Ron - Bank of America Brian Tanquilut - Jefferies Jason Cassorla - Citibank Josh Raskin - Nephron Research Operator Good afternoon, and welcome to Cano Health's Third Quarter 2022 Earnings Call. Currently, all participants are in a listen-only mode.

Third Point's Daniel Loeb (Trades, Portfolio) disclosed earlier this week he reduced his firm's stake in Cano Health Inc. ( CANO , Financial) by 26.1% as the stock continues to decline this month.